| __timestamp | BioMarin Pharmaceutical Inc. | Ionis Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 751040000 | 214161000 |
| Thursday, January 1, 2015 | 889895000 | 283703000 |
| Friday, January 1, 2016 | 1116854000 | 346620000 |
| Sunday, January 1, 2017 | 1313646000 | 507666000 |
| Monday, January 1, 2018 | 1491212000 | 599674000 |
| Tuesday, January 1, 2019 | 1704048000 | 1123000000 |
| Wednesday, January 1, 2020 | 1860455000 | 729000000 |
| Friday, January 1, 2021 | 1846275000 | 810000000 |
| Saturday, January 1, 2022 | 2096039000 | 587000000 |
| Sunday, January 1, 2023 | 2419226000 | 787647000 |
| Monday, January 1, 2024 | 2853915000 | 705138000 |
In pursuit of knowledge
In the competitive landscape of biotechnology, BioMarin Pharmaceutical Inc. and Ionis Pharmaceuticals, Inc. have showcased distinct revenue trajectories over the past decade. Since 2014, BioMarin has consistently outpaced Ionis, with its revenue growing by over 220% by 2023. This growth is highlighted by BioMarin's impressive leap from approximately $750 million in 2014 to nearly $2.42 billion in 2023. In contrast, Ionis Pharmaceuticals, while experiencing a respectable growth of around 270%, saw its revenue rise from $214 million to $788 million in the same period.
BioMarin's robust performance can be attributed to its strategic focus on rare genetic diseases, which has driven its revenue to new heights. Meanwhile, Ionis, a pioneer in RNA-targeted therapeutics, continues to innovate, albeit at a slower revenue growth pace. This comparison underscores the dynamic nature of the biotech industry, where innovation and strategic focus are key to financial success.
Comparing Revenue Performance: Novo Nordisk A/S or Ionis Pharmaceuticals, Inc.?
Bristol-Myers Squibb Company or BioMarin Pharmaceutical Inc.: Who Leads in Yearly Revenue?
Teva Pharmaceutical Industries Limited vs BioMarin Pharmaceutical Inc.: Annual Revenue Growth Compared
Teva Pharmaceutical Industries Limited and Ionis Pharmaceuticals, Inc.: A Comprehensive Revenue Analysis
Annual Revenue Comparison: Biogen Inc. vs BioMarin Pharmaceutical Inc.
Revenue Insights: Viatris Inc. and Ionis Pharmaceuticals, Inc. Performance Compared
Who Generates More Revenue? Bio-Techne Corporation or BioMarin Pharmaceutical Inc.
Comparing Revenue Performance: BioMarin Pharmaceutical Inc. or Catalent, Inc.?
BioMarin Pharmaceutical Inc. and Xencor, Inc.: A Comprehensive Revenue Analysis
Revenue Insights: Ionis Pharmaceuticals, Inc. and Veracyte, Inc. Performance Compared
Ionis Pharmaceuticals, Inc. vs Arrowhead Pharmaceuticals, Inc.: Annual Revenue Growth Compared
Ionis Pharmaceuticals, Inc. or Celldex Therapeutics, Inc.: Who Leads in Yearly Revenue?